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Abstract A new and simple procedure for the determina-
tion of parathion in human whole blood and urine using
direct immersion (DI) solid-phase microextraction (SPME)
and gas chromatography/mass spectrometry (GC/MS) is
presented. This technique was developed using only
100 μL of sample, and ethion was used as internal standard
(IS). A 65-μm Carbowax/divinylbenzene (CW/DVB)
SPME fibre was selected for sampling, and the main
parameters affecting the SPME process such as extraction
temperature, adsorption and desorption time, salt addition,
agitation and pH effect were optimized to enhance the
sensitivity of the method. This optimization was also
performed to allow the qualitative determination of para-
thion’s main metabolite, paraoxon, in blood. The limits
of detection and quantitation for parathion were 3 and
10 ng/mL for urine and 25 and 50 ng/mL for blood,
respectively. For paraoxon, the limit of detection was
50 ng/mL in blood. The method showed linearity between
the LOQ and 50 μg/mL for both matrices, with correlation
coefficients ranging from 0.9954 to 0.9999. Precision and
accuracy were in conformity with the criteria normally
accepted in bioanalytical method validation. The mean
absolute recoveries were 35.1% for urine and 6.7% for
blood. Other parameters such as dilution of sample and
stability were also validated. Its simplicity and the fact that
only 100 μL of sample is required to accomplish the analysis
make this method useful in forensic toxicology laboratories
to determine this compound in intoxications, and it can be
considered an alternative to other methods normally used for
the determination of this compound in biological media.
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Introduction
Parathion [O,O-diethylO-(4-nitrophenyl)phosphorothioate]
is an organophosphorous pesticide of very high mammalian
toxicity [1], and was synthesized by Schrader in the 1940s
[2]. It acts by the irreversible inhibition of cholinesterases,
which are responsible for hydrolysing, and thereby deacti-
vating, the neurotransmitter acetylcholine [3, 4]. It may be
absorbed through the skin, by inhalation and via the
gastrointestinal tract. After absorption it is rapidly metab-
olized to paraoxon, in which the sulfur atom is replaced by
oxygen. Both compounds are rapidly hydrolysed by plasma
and tissue esterases to produce diethylthiophosphoric acid
(DETP), diethylphosphoric acid (DEP) and p-nitrophenol.
These products are largely excreted in urine and account for
the majority of a dose of parathion; however, the parent
compound is also excreted in its unchanged form [5].
Intoxication symptoms are similar to those produced by
other cholinesterase inhibitors and include respiratory
difficulty, excessive salivation, miosis, nausea, vomiting,
muscle weakness and paralysis [6]. Toxic levels in plasma
are reported to be in the range of 0.01 to 0.08 μg/mL [6].
Several methodologies have been developed for sample
preparation prior to analysis of parathion in biological or
environmental samples [7–10] and these usually involve
time- and solvent-consuming techniques. Solid-phase
microextraction (SPME), a rapid and simple sampling
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technique developed by Arthur and Pawliszyn in the early
1990s at the University of Waterloo (Ontario, Canada), can
provide an alternative to those methods [11]. In fact, the
sampling, extraction, concentration and sample introduction
steps are combined into a single uninterrupted process,
which results in high sample throughput [12]. SPME has
been successfully applied for the determination of pesti-
cides in environmental samples [13, 14], food [15–17] and
biological samples [18–23]. Only three papers [24–26]
describe the determination of parathion in biological
samples by means of SPME, using the headspace sampling
technique. However, to the best of our knowledge, the use
of the direct immersion approach to determine parathion in
this kind of sample has not been published in the literature.
This paper describes a new method based on direct
immersion SPME combined with gas chromatography/mass
spectrometry to determine parathion in blood and urine,
using only 0.1 mL of sample.
Experimental
Reagents
Analytical standards, parathion and paraoxon were pur-
chased from Riedel-de Haën (Seelze, Germany), and ethion
(internal standard, IS), an organophosphorous insecticide
not commercially available in Portugal, was obtained from
Polyscience Corp. (Niles, IL, USA). All pesticide standards
were of 98–99% purity.
Methanol (HPLC grade), phosphoric acid, sodium
hydrogenphosphate and sodium chloride (analytical grade)
were obtained from Merck Co (Darmstadt, Germany).
Stock standard solutions at 1,000 μg/mL for each
compound were prepared in methanol and stored at −20 °C
in the dark. The analytes were stable under these conditions
for at least 6 months. Subsequently working solutions at
100, 10 and 1 μg/mL for parathion and paraoxon, and at
100 μg/mL for ethion, were prepared by appropriate
dilution of the stock solutions with methanol. These
solutions were stored protected from light at 4 °C.
Phosphate buffer solutions (0.07 M) were prepared by
mixing solutions of phosphoric acid and sodium hydro-
genphosphate in variable proportions, according to the
desired pH [27].
Biological samples
Fresh human blood was obtained from the excess supplies
of the Portuguese Institute of Blood (outdated transfusions),
preserved with citrate phosphate dextrose (1:7), and was
stored at −20 °C until analysis. Urine specimens were
obtained from healthy supposed non-exposed subjects
(laboratory personnel).
Instrumentation
The SPME device for manual extraction and the coated
fibres, 100-μm polydimethylsiloxane (PDMS) and 65-μm
Carbowax/divinylbenzene (CW/DVB), were purchased
from Supelco (Bellefonte, PA, USA). Before the first use,
new fibres were conditioned as recommended by the
manufacturer by heating them in the injector port of the
chromatographic system for 30 min, at 250 °C for PDMS
and 220 °C for CW/DVB fibres.
Chromatographic analysis was performed using an HP
6890 gas chromatograph equipped with a model 5973 mass
selective detector (Hewlett-Packard, Waldbronn, Germany).
A capillary column (12 m×0.25-mm I.D., 0.25-μm film
thickness) packed with 5% phenylmethylsiloxane (Ultra 2),
supplied by J & W Scientific (Folsom, CA, USA), was
used.
Chromatographic conditions were as follows: initial
oven temperature was 100 °C for 2 min, which was
increased by 10 °C/min to 200 °C, held for 1 min, and
finally elevated by 24 °C/min to 270 °C, kept constant for
2 min. The temperatures of the injection port and detector
were set to 240 and 280 °C, respectively. Splitless injection
mode was adopted, and the carrier gas was helium at a
constant flow rate of 1 mL/min. The mass spectrometer was
operated with a filament current of 300 μA and an electron
energy of 70 eV in the electron impact (EI) mode.
Quantitation was done in the selected ion monitoring
(SIM) mode, and the ions were monitored at m/z 109, 139
and 186 for parathion, at m/z 109, 149, 275 for paraoxon,
and at m/z 231, 153 and 125 for ethion: in each case the
quantitation ion was at m/z 109.
The retention times were 11.10, 11.80 and 14.48 min for
paraoxon, parathion and IS, respectively, obtaining a good
separation of all compounds.
Extraction procedures
Blood
For sample preparation, 10 μL IS (100 μg/mL) was added
to 100 μL blood. A final volume of 1 mL was obtained
after appropriate dilution with deionised water. The sample
was vortex-mixed for 30 s, and the CW/DVB-coated fibre
was directly immersed in it for 60 min at 60 °C, without
stirring. After extraction the fibre was retracted and washed
by immersion in deionised water for 5 s, after which it was
thermally desorbed in the injector port of the GC for 1 min
at 240 °C.
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Urine
The procedure adopted to extract urine samples was similar
to that of the blood, except that the extraction temperature




Before the application of the extraction technique to the
samples, several experiments with spiked blood and urine
samples (1 μg/mL) were carried out in order to select the
optimum conditions for the extraction process. Each
experiment was assayed thrice and individually for each
selected pesticide, including IS, in each particular matrix. It
should be stated that all the parameters related to paraoxon
were only optimized for blood samples, because this
metabolite is normally not detected in urine [5].
The optimized parameters were type of fibre coating,
adsorption and desorption time, extraction temperature,
agitation, salt addition and pH effect. Because SPME is an
equilibrium process, rather than exhaustive [28], this
systematic optimization of the experimental procedure was
deemed necessary to achieve higher yields of the analytes
and enhance method sensitivity.
The first parameter studied was the type of fibre coating.
Two types of fibre coating were assayed: 100-μm PDMS
and 65-μm CW/DVB. Peak areas obtained with each fibre
were compared, and the CW/DVB fibre was chosen
because it extracted 2 and 3 times the amount of parathion
than the PDMS fibre in urine and blood, respectively.
In SPME the extraction involves the partitioning of the
analytes between the matrix and fibre coating [29].
Therefore, the optimization of the contact time between
these two phases is crucial to enhance method sensitivity.
To find the best adsorption time, spiked blood and urine
samples were extracted during several controlled times
(1, 5, 10, 15, 25, 35, 40, 60, 90 and 180 min). After each
extraction, the fibre was desorbed for 3 min at 240 °C in the
injector port of the GC. The area counts were plotted
against the extraction time (Fig. 1). We observed an
increase in the extraction yield with the increase in the
extraction time. Equilibrium was not reached by using these
extraction times, and 180 min yielded the highest peak
areas. However, the selected time for adsorption was not
180 min, as it would waste the aim of a rapid method; a
good compromise between acceptable sensitivity and
extraction time therefore had to be established. The selected
adsorption time was 60 min for both matrices.
This is possible because SPME is an equilibrium
process, as stated above. However, equilibrium is not a
prerequisite for a quantitative method. In fact, the equilib-
rium time is independent of the analyte concentration in the
sample. On the other hand, the absolute amount of analyte
extracted at a given time is linearly proportional to its
concentration [30]. In this way, quantitation can be
performed precisely and accurately, as long as the extrac-
tion time is the same for calibrators and samples.
The optimization of desorption time aims at achieving
the quantitative desorption of the analytes. On the other
hand, and because a single coated fibre is designed to last
for several extraction/desorption cycles, the possibility of
carry-over of analytes is an important issue that must be
excluded during method optimization. Several desorption
times (1, 2, 3, 4 and 6 min) and two different injector
temperatures (220 and 240 °C) were tested. On the basis of
peak area evaluation, the best desorption conditions were
found to be 1 min at 240 °C. The carry-over of analytes was
excluded by analysis of blood and urine samples spiked
with high amounts of the compounds (100 μg/mL). After
the chromatographic run, the fibre was immediately sub-
jected to the same desorption conditions. No peaks were
Fig. 1 Adsorption time profile
for parathion, paraoxon and IS
in blood and urine samples
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observed after the second desorption, which excluded the
carry-over of analytes.
The temperature effect on the extraction yield was
evaluated by varying the temperature between 25 °C and
60 °C for blood, and between 25 °C and 90 °C for urine
samples. The extraction yield increased with the tempera-
ture (Fig. 2) in both matrices, and therefore the selected
temperatures were 60 °C for blood and 90 °C for urine. A
60-min extraction of urine samples at 90 °C yielded 4 times
more analyte than 180 min at room temperature.
Blood samples could not be heated above 60 °C, because
of coagulation (we experienced coagulation of the samples
Fig. 3 Effect of salt addition on
the extraction yield
Fig. 2 Extraction yield of the
analytes from urine (a) and
blood (b) samples versus
extraction temperature
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at 70 °C), and a 60-min extraction at this temperature
yielded similar amounts of the analytes when compared to a
180-min extraction at room temperature.
In equilibrium, the temperature increase during extrac-
tion negatively affects the extraction recovery, because the
distribution constant between the sample and the fibre
coating decreases. However, under non-equilibrium con-
ditions, it is possible to improve sensitivity by increasing
the temperature at which the extraction is performed [30].
This fact may explain our results, since the time selected for
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Fig. 4 Merged ion chromato-
grams of blood samples spiked
with parathion at 0.05 μg/mL
(a) and paraoxon at 1 μg/mL
(b), and a urine sample spiked
with parathion at 0.01 μg/mL
(c), and from blank samples
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extraction was shorter than the equilibrium time (as above
mentioned, equilibrium was not reached even after
180 min).
To evaluate the influence of agitation on the extracted
amount of parathion and paraoxon, blood and urine samples
spiked at 1 μg/mL were analysed with and without
agitation during the adsorption process, and peak areas
were compared. Sample agitation did not significantly
improve the extraction yield, and therefore it was decided
not to agitate the samples during the extraction, as it would
complicate the process.
The effect of pH on the extraction yield was evaluated
by diluting blood and urine samples spiked with 1 μg/mL
of each pesticide in phosphate buffer 0.07 M (pH 5, 6, 7
and 8) instead of water. The peak areas obtained for each
of the pH values were compared, and the highest peak
areas were obtained at pH 8. However, the dilution of the
sample with water yielded larger recovery of the analytes,
which may have been due to an increase in salt
concentration derived from the phosphate buffer. Therefore
this study was carried out by diluting the sample with
water.
Salt addition can improve the extraction yield as a
result of a “salting out” effect. The effect of ionic
strength on extraction efficiency was evaluated by
analysing the amount of pesticides extracted in sample
solutions containing 0, 0.375, 0.75, 1.5, 3, 5 and 10%
sodium chloride.
Figure 3 illustrates the obtained results, and as can be
seen the extracted amount diminished with the increase of
salt concentration in the sample, which corroborates the
results obtained in the pH experiments. Therefore this study
was performed without salt addition.
Method validation
After optimization the methodology was validated accord-
ing to internationally accepted criteria [31–33]. The studied
parameters were selectivity, calibration curves, precision
and accuracy, limits of detection and quantitation, recovery,
dilution effect and stability.
The selectivity of the method was evaluated by analysis
of ten blank blood and urine samples of different origin.
The obtained chromatograms were compared with those
obtained from blood and urine samples spiked with
parathion and paraoxon (Fig. 4). The peaks were well-
separated and no interferences were observed. Furthermore,
the interference of other substances that might eventually be
present in the samples, such as other pesticides, was also
evaluated, and could be excluded due to different retention
times and/or mass spectra. For example, chlorpyrifos (an
organophosphorous insecticide) has the same retention time
of parathion. However, their mass spectra are different, and
therefore it is possible to separate them, as can be seen in
Fig. 5.
Linearity of the method for parathion was established on
spiked blood and urine samples prepared and analysed
using the described extraction procedures in the ranges of
0.05 to 50.00 μg/mL and 0.01 to 50.00 μg/mL, respectively
(ten calibrators each), each calibration level being analysed
6 times. The calibration curves were obtained by plotting
the peak/area ratio between the analyte and ethion against
analyte concentration. Calibration data is presented in
Table 1. This parameter was only studied for parathion,
since paraoxon was determined qualitatively.
The calibrators’ accuracy, i.e. mean relative error (bias)
between measured and spiked concentrations, was consid-
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Fig. 5 Merged ion chromato-
grams of parathion (ion 109)
and chlorpyrifos (ion 97)
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ered adequate, being within ±15% of the nominal concen-
tration for all concentration levels, except for the lower
limit of quantitation (LLOQ), for which 20% was consid-
ered acceptable [31, 32].
The limit of quantitation (LOQ) was defined as the lowest
parathion concentration that could be measured with
adequate precision (coefficient of variation of less than
20%) and accuracy (within ±20% of the nominal concentra-
tion), and was found to be 10 ng/mL for urine and 50 ng/mL
for blood. The limits of detection (LOD), defined as the
lowest tested concentration yielding a signal-to-noise ratio
higher than 3, were 25 and 3 ng/mL for parathion in blood
and urine respectively, and 50 ng/mL for paraoxon in blood.
LOD of paraoxon in urine was not determined because as
stated above this metabolite is rapidly hydrolysed [5]. These
limits were close to the published values for parathion
determination in blood by means of SPME [24–26], and
were obtained using a smaller sample volume (100 μL
versus 300 and 500 μL). The determination of parathion in
urine has not yet been published in the literature, so we
cannot compare our results.
Intraday precision and accuracy were evaluated by
analysing in the same day 6 replicates of blank urine
samples spiked with parathion at LOQ, 0.25, 2.50, 10.0,
25.0 and 50.0 μg/mL for blood, and at LOQ, 0.05, 0.10,
0.50, 2.50, 10.0 and 50 μg/mL for urine. Interday precision
and accuracy were determined at the same concentration
levels over a period of 5 months. The values of intra- and
interday precision in both matrices were less than 13%, and
the measured concentrations did not deviate more than 12%
from the nominal concentration (Table 2).
Absolute recoveries of parathion were determined at 0.5,
5.0 and 25.0 μg/mL in urine and blood. For each
concentration, 6 blank samples were spiked with parathion
and analysed using the abovementioned procedures. The
obtained peak areas were compared with those obtained
from a splitless injection of 1 μL methanolic solutions
containing the same amount of the analyte. The mean
calculated values were 35.1% for urine and 6.7% for blood.
These recovery values are higher than the published values
for the determination of parathion in blood samples using
SPME [24, 26]. We believe that the high temperature at
which the extractions were performed contributed to the
higher recoveries observed. However, these values are quite
low when compared with the recovery values normally
observed in other analytical methods (liquid–liquid extrac-
tion or solid-phase extraction). This is explained by the fact
that SPME is an equilibrium process, rather than exhaus-
tive. However, in this technique all the extracted amount of
analyte is injected into the chromatographic system, unlike




















Blood 0.50 6.7 0.05 0.05 6.23 8.15 0.05 9.24 −9.79
0.25 0.25 1.75 1.87 0.26 1.21 2.41
5.0 6.6 2.50 2.32 1.82 −7.27 2.42 5.67 −3.33
10.0 9.65 2.98 −3.50 9.08 4.69 −9.16
25.0 6.7 25.0 26.80 3.20 7.20 27.89 6.34 11.59
50.0 52.08 1.04 4.17 46.26 5.03 −7.47
Urine 0.50 45.6 0.01 0.01 5.79 −8.65 0.01 5.68 5.41
0.05 0.05 3.31 6.58 0.04 12.60 −9.36
0.10 0.09 3.35 −3.36 0.09 9.79 −8.20
5.0 37.6 0.50 0.50 4.65 −0.33 0.54 6.91 7.82
2.50 2.43 1.78 −6.21 2.43 2.96 −2.65
25.0 21.9 10.0 10.05 3.97 4.86 9.97 5.94 −0.28
50.0 51.91 6.02 3.82 47.92 6.60 −4.15
a CV coefficient of variation
b Bias [(measured concentration−nominal concentration)/nominal concentration]×100






















aMean value and standard error
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other extraction techniques, in which the extracts must be
evaporated and reconstituted in a solvent, from which only
a small aliquot is injected into the system. On the other
hand, SPME is a highly selective technique, and the
obtained chromatograms are in general cleaner than those
obtained with other extraction methods. In this way, it is
possible to detect and quantitate small amounts of the
compounds, in spite of the low recovery observed.
The validation of a partial sample volume was done by
spiking blood and urine samples with concentrations above
the higher level of calibration. Five replicates of each
sample were analysed after appropriate dilution with blank
matrix to the validated concentration range (dilution factors
of 2, 4 and 10). The calculated concentrations of these
diluted samples, after multiplication by their respective
dilution factors, showed a precision of less than 10% for
blood and 13% for urine samples.
In order to study stability in processed samples at two
concentration levels, blood and urine were spiked with 0.25
and 10 μg/mL of parathion, and extracted using the
abovementioned procedures (n=3). However, after extrac-
tion the fibre was retracted, but it was not desorbed
immediately in the GC injector. Instead, the fibre was left
standing at room temperature for controlled time intervals
(5, 10, 15, 20 and 30 min) before desorption. The measured
concentrations for each tested time did not deviate more
than 10% from the nominal concentration, and therefore the
analyte is stable on the fibre coating for at least 30 min at
room temperature.
Short-term stability was evaluated at the same concen-
tration levels (n=3). Blood and urine were spiked and these
samples were left at room temperature for 24 h. These
samples were compared with samples prepared and ana-
lysed in the same day, and the obtained values for precision
were less than 4% for blood and 13% for urine samples.
Freeze and thaw stability was also evaluated in triplicate
at two concentration levels. Blood and urine samples were
spiked with 0.25 and 10 μg/mL of parathion, and these
aliquots were stored at the intended storage temperature for
24 h, after which they were thawed unassisted at room
temperature. When completely thawed, the samples were
re-frozen for 12–24 h under the same conditions. This
freeze/thaw cycle was repeated twice more, and the samples
were analysed after the third cycle. These samples were
compared to samples prepared and analysed in the same
day, and the analytes were stable for at least 3 freeze/thaw
cycles (the measured concentrations did not deviate more
than 11% from the nominal concentration for both
matrices).
To demonstrate the applicability of this procedure,
samples proceeding from 25 cases of acute intoxication
were analysed and the obtained results are presented in
Table 3. The compound was identified by its retention time
and by the relative amounts of the selected ions. A typical
chromatogram of a blood sample is shown in Fig. 6.
Parathion is the second most detected pesticide in acute
organophosphorous intoxications (mainly suicides) in Por-
tugal, in spite of the fact that its commercialization has been
prohibited since 1995, which indicates that people have
stored it, particularly in rural areas. The high levels detected
in some of the samples are consistent with the route of
administration normally seen in these cases, in which
people tend to ingest large amounts of the pesticide. On
the other hand, there is the possibility of contamination
during autopsy procedures, as well as post-mortem redis-
tribution phenomena.
Concerning paraoxon, it was not detected in any of the
analysed samples. We believe that the SPME method was
not responsible for not detecting this compound, since it
was optimized, and a low limit of detection was obtained. It
is possible that this compound was not detected because of
its lack of stability in the frozen samples, which was not
studied. Furthermore, the conservation conditions of the
samples between their collection at autopsy and the arrival
at the laboratory are not known.




























n.a. sample not available
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Concerning the urine samples, in most of the cases this
sample was not available, since in most post-mortem
situations the pathologist does not send urine samples for
analysis. Therefore, only 5 urine samples could be
analysed.
Conclusions
We have developed a simple and rapid method for the
quantitation of parathion in blood and urine using DI-SPME.
The procedure is sensitive and specific, presenting low
limits of detection and quantitation, and moreover
requires only 100 μL of sample. In this technique no
organic solvent is required to accomplish the analysis,
which is important from an environmental standpoint, since
waste disposal is avoided. There is no need to evaporate
and reconstitute the extracts, and therefore this methodol-
ogy may be an alternative to the more time-consuming
extraction methods, like liquid–liquid or solid-phase ex-
traction, for the determination of this organophosphorous
insecticide in biological media, both in clinical and forensic
toxicology.
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